Activation of PPAR pathway is also observed in Wdr13−/0 primary hepatocytes when treated with CCl4, which confirms that hypertriglyceridaemia seen in vivo is indeed due to the liver-specific absence of WDR13. The gene discussed is WDR13; the disease is hypertriglyceridemia.